| abstract |
The present invention relates to an ACAT inhibitor (for example, F-1394, Abashimibe, Pakutimibe (CS505), Efurushimibe (F12511), Eldasimibe, NTE 122, AS183, KW3033, E5324, FY087, FCE27677, CI976, TEI6522, K604, Octimivert, FR179254 , S58-035 F-1394, Abashimibe, Pakutimibe (CS505), Efurushimibe (F12511), Eldasimibe, NTE 122, AS183, KW3033, E5324, FY087, FCE27677, CI976, TEI6522, K604, Octimivert, FR179254 and S58-035) Use of the mixture, compositions containing it, and methods for the prevention or treatment of fibrosis, for the prevention or reduction of collagen deposition in tissues, and for the prevention and reduction of excess fibrous connective tissue About. |